microprolactinoma

microprolactinoma

[-prōlak′tinō′mə]
a prolactin-secreting pituitary tumor less than 10 mm in diameter. Microprolactinomas seldom enlarge, and some resolve spontaneously. Most patients experience a return to ovulatory menstrual cycles and fertility with treatment.

microprolactinoma

A prolactin-secreting tumour which measures less than 10 mm in greatest dimension; it accounts for up to 30% of all pituitary adenomas.
Mentioned in ?
References in periodicals archive ?
Hallazgos de la RM de acuerdo con los valores de prolactina * Nivel de RM Microprolactinoma prolactina normal (ng/mL) 25-50 8 14 51-100 7 6 101-200 3 2 201 o mas 0 1 Total 18 23 Nivel de Macroprolactinoma Otros prolactina hallazgos (ng/mL) 25-50 0 1 51-100 0 0 101-200 3 0 201 o mas 0 0 Total 3 1 * Una paciente tenia aracnoidocele Tabla 4.
Basados en su tamano, se clasifican en microprolactinomas (menos de 10 mm) y macroprolactinomas (10 mm o mas).
De las 26 pacientes con prolactinomas diagnosticados por RM contrastada de la silla turca, 23 tenian microprolactinomas y 3, macroprolactinomas.
Estrogen therapy may be used to replace dopamine agonists in women with idiopathic Hyperprolactinemia (IH) or microprolactinoma who do not want to become pregnant and those suffering from estrogen deficiency, particularly if they are resistant to or intolerant of dopamine agonists.
Some of these patients may have radiologically undetected microprolactinoma, however, some may present with macroprolactinemia.
Nosotros utilizamos la bromocriptina (2,5 mg) a razon de media tableta diaria en un paciente portador de un microprolactinoma que no tuvo respuesta clinica, con crecimiento tumoral, decidiendose posteriormente la cirugia.
2008) have documented several cases of prolactinoma (lactotroph adenoma) following high-dose estrogen treatment in MTF patients with normal serum prolactin levels prior to therapy, as well as the formation of a pituitary microprolactinoma in a patient on normal-dose estrogen for 14 years.
Asymptomatic patients harboring microprolactinomas do not need to be prescribed dopamine agonists.